Cancer of larynx, Hypopharynx, Nasopharynx. Malignant neoplasm of larynx, Malignant neoplasm of hypopharynx, Malignant of nasopharynx
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with cancers of head and neck region include progressive larynx cancer, progressive hypopharynx cancer and nasopharynx cancer; undergone radiation with 5000 centigray by linear accelerator; using oral protective shield Exclusion criteria: Cardiovascular diseases; gastrointestinal diseases
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Unstimulated whole saliva. Timepoint: 2, 4 and 6 weeks after initiation of radiotherapy. Method of measurement: With mililiter by graduated measuring tube by spitting method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Shahid Sadoughi University of Medical Sciences of Yazd